ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2019

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies.

Paula J Busse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.